|
Spdr S&p 500 Etf Tr Tr Unit Put Option
(SPY)
|
24.9 |
$89M |
|
250k |
357.18 |
|
Sanofi Sponsored Adr
(SNY)
|
5.8 |
$21M |
|
550k |
38.02 |
|
Establishment Labs Holdings Ord
(ESTA)
|
5.0 |
$18M |
|
327k |
54.61 |
|
Chinook Therapeutics
|
4.5 |
$16M |
|
814k |
19.66 |
|
Astrazeneca Sponsored Adr
(AZN)
|
3.8 |
$14M |
|
250k |
54.84 |
|
Global Blood Therapeutics In
|
3.6 |
$13M |
|
190k |
68.10 |
|
Ishares Tr Russell 2000 Etf Put Option
(IWM)
|
3.2 |
$12M |
|
70k |
164.91 |
|
Madrigal Pharmaceuticals
(MDGL)
|
3.2 |
$11M |
|
175k |
64.99 |
|
Lantheus Holdings Inc Common Stock Usd 0.01
(LNTH)
|
3.1 |
$11M |
|
160k |
70.33 |
|
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
3.1 |
$11M |
|
11M |
1.01 |
|
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
2.9 |
$10M |
|
100k |
103.26 |
|
Kura Oncology
(KURA)
|
2.7 |
$9.7M |
|
713k |
13.66 |
|
Inari Medical Ord
|
2.4 |
$8.7M |
|
120k |
72.64 |
|
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
2.4 |
$8.5M |
|
10M |
0.85 |
|
Ventyx Biosciences
(VTYX)
|
1.7 |
$5.9M |
|
170k |
34.91 |
|
Point Biopharma Global
|
1.6 |
$5.8M |
|
747k |
7.73 |
|
GSK Sponsored Adr
(GSK)
|
1.5 |
$5.4M |
|
185k |
29.43 |
|
Verona Pharma Sponsored Adr
(VRNA)
|
1.5 |
$5.3M |
|
515k |
10.22 |
|
Bellus Health Com New
|
1.4 |
$5.0M |
|
474k |
10.56 |
|
Springworks Therapeutics
(SWTX)
|
1.4 |
$5.0M |
|
175k |
28.53 |
|
Penumbra Call Option
(PEN)
|
1.3 |
$4.7M |
|
25k |
189.60 |
|
Cymabay Therapeutics
|
1.3 |
$4.5M |
|
1.3M |
3.50 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
1.3 |
$4.5M |
|
7.5M |
0.60 |
|
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.2 |
$4.4M |
|
10M |
0.44 |
|
Rocket Pharmaceuticals
(RCKT)
|
1.2 |
$4.3M |
|
268k |
15.96 |
|
Morphic Hldg
(MORF)
|
1.2 |
$4.1M |
|
147k |
28.30 |
|
Arcellx Common Stock
(ACLX)
|
1.1 |
$3.9M |
|
210k |
18.77 |
|
Zentalis Pharmaceuticals
(ZNTL)
|
1.0 |
$3.7M |
|
170k |
21.66 |
|
Astria Therapeutics
(ATXS)
|
1.0 |
$3.6M |
|
400k |
9.04 |
|
Arya Sciences Acquisitn Corp Class A Ord Shs
|
1.0 |
$3.5M |
|
353k |
9.83 |
|
Cytokinetics Com New
(CYTK)
|
0.9 |
$3.1M |
|
65k |
48.45 |
|
Geron Corporation Call Option
(GERN)
|
0.8 |
$3.0M |
|
1.3M |
2.34 |
|
Cogent Biosciences
(COGT)
|
0.6 |
$2.3M |
|
154k |
14.92 |
|
Celldex Therapeutics Com New
(CLDX)
|
0.6 |
$2.2M |
|
80k |
28.11 |
|
Aclaris Therapeutics
(ACRS)
|
0.6 |
$2.1M |
|
136k |
15.74 |
|
Vincerx Pharma Com New
|
0.6 |
$2.1M |
|
1.5M |
1.38 |
|
Invesco Currencyshares Euro Euro Shs Put Option
(FXE)
|
0.5 |
$1.8M |
|
20k |
90.45 |
|
Prometheus Biosciences
|
0.4 |
$1.5M |
|
25k |
59.00 |
|
Precigen Note 3.500% 7/0 (Principal)
|
0.4 |
$1.5M |
|
1.5M |
0.97 |
|
Kalvista Pharmaceuticals
(KALV)
|
0.4 |
$1.4M |
|
96k |
14.51 |
|
Milestone Pharmaceuticals Call Option
(MIST)
|
0.4 |
$1.3M |
|
137k |
9.19 |
|
Lianbio Sponsored Ads
(LIANY)
|
0.3 |
$1.1M |
|
550k |
1.99 |
|
Invesco Currencyshares Brit Brit Poun Strl Put Option
(FXB)
|
0.3 |
$1.1M |
|
10k |
107.30 |
|
Context Therapeutics
(CNTX)
|
0.3 |
$981k |
|
884k |
1.11 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
0.3 |
$975k |
|
243k |
4.02 |
|
Alpine Immune Sciences
|
0.2 |
$792k |
|
110k |
7.20 |
|
Nautilus Biotechnology
(NAUT)
|
0.2 |
$790k |
|
373k |
2.12 |
|
Verve Therapeutics Call Option
(VERV)
|
0.2 |
$687k |
|
20k |
34.35 |
|
Viking Therapeutics
(VKTX)
|
0.2 |
$680k |
|
250k |
2.72 |
|
Iveric Bio Call Option
|
0.2 |
$538k |
|
30k |
17.93 |
|
Immatics *w Exp 07/01/202
(IMTXW)
|
0.1 |
$507k |
|
187k |
2.71 |
|
Renovacor
|
0.1 |
$503k |
|
200k |
2.52 |
|
Tango Therapeutics
(TNGX)
|
0.1 |
$297k |
|
82k |
3.62 |
|
Vickers Vantage Corp I *w Exp 09/15/202
|
0.0 |
$17k |
|
100k |
0.17 |
|
Renovacor *w Exp 99/99/999
|
0.0 |
$6.0k |
|
75k |
0.08 |
|
Medicus Sciences Acquisition *w Exp 02/12/202
|
0.0 |
$3.0k |
|
33k |
0.09 |